MicroRNA-217 acts as a tumor suppressor and correlates with the chemoresistance of cervical carcinoma to cisplatin
OncoTargets and Therapy Feb 01, 2019
Yin Z, et al. - Researchers analyzed 65 pairs of cervical carcinoma tissues and matched normal tissues to determine the role of microRNA-217 (miR-217) in the growth, migration, and invasion of cervical carcinoma and as well as the role of miR-217 in the chemosensitivity of cervical carcinoma cell to cisplatin. They measured miR-217 levels using quantitative real-time-PCR assay. They used Cell Counting Kit-8, flow cytometry, wound healing, and Transwell invasion assays to determine the roles of miR-217 on the growth, apoptosis, migration, and invasion of cervical cancer SiHa and Ca-Ski cells, respectively. In vivo, the influence of miR-217 on the growth of cervical carcinoma cell was determined via the xenograft tumor model. Findings revealed a significantly lower miR-217 level in cervical carcinoma tissues vs that in noncancerous tissues. As a result of upregulation of miR-217, inhibition of the aggressiveness phenotypes of cervical carcinoma cell happened via regulation of V-Ki-Ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS). Also, upregulation of miR-217 increased the sensitivity of cervical cancer cell to cisplatin.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries